{
    "organizations": [],
    "uuid": "159d970cdc3e4ab78b60c9457a55faa1eae59484",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-beijing-sl-pharmaceutical-sees-fy/brief-beijing-sl-pharmaceutical-sees-fy-2018-h1-net-profit-up-35-pct-to-65-pct-idUSL3N1S2337",
    "ord_in_thread": 0,
    "title": "BRIEF-Beijing SL Pharmaceutical sees FY 2018 H1 net profit up 35 pct to 65 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Beijing SL Pharmaceutical Co Ltd\n* Says it sees FY 2018 H1 net profit to increase by 35 percent to 65 percent, or to be 314.2 million yuan to 384.1 million yuan\n* Says FY 2017 H1 net profit was 232.8 million yuan\n* Comments that increased sales of new products as main reason for the forecast\nSource text in Chinese: goo.gl/Qgub3e\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-25T15:45:00.000+03:00",
    "crawled": "2018-04-26T20:41:50.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "beijing",
        "sl",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "see",
        "fy",
        "h1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "h1",
        "net",
        "profit",
        "million",
        "yuan",
        "comment",
        "increased",
        "sale",
        "new",
        "product",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}